TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS

摘要

The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically acceptable form thereof for use in the treatment and/or prevention of laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.

主权项

1. A method of treating or preventing a metabolic disorder in an equine comprising administering one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof.